FDA grants Fast Track designation to NVC-001 as the SUNBEAM-LMNA trial evaluates the safety and potential of a one-time gene therapy for aggressive inherited heart disease with no approved ...
Chico Enterprise-Record on MSN
Enloe Health to receive $9M to expand cell, gene therapy access
Enloe Health announced Monday that was selected to receive a $9 million grant from the California Institute for Regenerative ...
The FDA has approved 'Otarmeni', the first gene therapy for congenital hearing loss (DFNB9) caused by OTOF gene mutations.It ...
A Bengaluru infant diagnosed with Spinal Muscular Atrophy at just five weeks old has successfully received gene replacement ...
Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "Preclinical Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
A new review charts how stem cell transplantation, lentiviral gene therapy, and CRISPR-based editing such as Casgevy are ...
A risk-adapted treatment strategy with intensified induction, extended consolidation, and maintenance therapy is associated ...
New data from an Eli Lilly study found that adults with moderate-to-severe psoriasis and obesity experienced broader immune ...
An experimental treatment combining gene therapy with specialized goggles has helped some people with advanced blindness ...
A gene therapy based on Nobel prize-winning science has partially restored sight in some blind patients, with a clinical ...
Sarepta Therapeutics Inc. no longer has to face a lawsuit accusing it of infringing a University of Pennsylvania gene therapy patent licensed by clinical-stage biotechnology company Regenxbio Inc.
New research conducted by the New England Journal of Medicine reports that an experimental optogenetic treatment has helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results